Healthtech Startups

Bexion Pharmaceuticals is a clinical-stage biopharmaceutical company developing biologic cancer therapies that target dysregulated sphingolipid metabolism to counter tumor survival and treatment resistance. Its lead program, BXQ-350, is being studied in patients with advanced solid tumors, including metastatic colorectal cancer.

1 investor

Beyeonics Vision develops the Beyeonics one, an ophthalmic exoscope that uses augmented reality and head-mounted display technology to provide surgeons with advanced visualization and real-time surgical data. The company serves ophthalmic surgeons by delivering enhanced visualization and decision support for surgical procedures.

1 investor

Beyond Capital Ventures is a venture capital firm investing in early-stage businesses addressing the needs of emerging consumers in India and East Africa, with a focus on healthcare, financial services, and agriculture.

1 investor

BezOkularow.pl is an online store selling contact lenses and related products, including toric, progressive, and colored lenses, lens solutions, eye drops, and accessories from brands such as Johnson & Johnson, Alcon, Cooper Vision, Bausch & Lomb, Horien, and Zeiss, as well as its own EyeLove brand. Operated by eCommerce Factory SA, it serves consumers in Poland with express 24h shipping.

1 investor

Behavioral Health Group operates a network of Joint Commission-accredited outpatient treatment centers specializing in personalized, evidence-based opioid recovery care across 20+ states. The company delivers comprehensive addiction treatment services to patients with opioid use disorders through its 110+ locations nationwide.

1 investor

BHS Technologies develops the RoboticScope, a digital robotic surgical microscope paired with a head-mounted display that lets microsurgeons operate hands-free in ergonomic postures. Founded in Innsbruck, Austria, it makes CE-marked, FDA-listed medical devices for microsurgery, sold in over 20 countries.

1 investor

Bible Chat is a mobile app that provides curated Bible verses and biblical content to help users deepen their faith and understanding of Scripture.

1 investor

Bifidice manufactures probiotic ice cream products containing Bifidobacterium Bifidice bacteria, designed to support digestive health and immune function. The company targets consumers seeking functional foods with clinically-supported health benefits.

1 investor

Bifido is a South Korean microbiome company that researches and develops Bifidobacterium strains and pharmabiotics — human microbiome-derived materials intended for the prevention or treatment of disease. It focuses on immune-related conditions such as rheumatoid arthritis and cancer, and produces probiotic strains including FDA-registered ingredients.

1 investor

Bikanta develops nanodiamond-based imaging probes for medical diagnostics and research, leveraging fluorescent properties to improve detection sensitivity in optical imaging applications.

1 investor

Bild develops AI-powered engineering co-pilots that automate document review, impact analysis, and regulatory workflows for medical device manufacturers. The platform helps hardware teams reduce bottlenecks in manufacturing documentation and design change management.

1 investor

Bilihome develops a wearable phototherapy device for treating neonatal jaundice in hospitals and home settings, enabling parents to maintain physical contact with their newborns during treatment. The company provides the device alongside remote monitoring services and implementation support for hospitals to adopt zero-separation care pathways.

1 investor

Bilix develops BRIXELLE-ONCO, a bilirubin nanoparticle technology that serves as a non-toxic drug carrier for anti-cancer agents, designed to reduce side effects in cancer treatment by improving drug delivery to tumor sites. The technology uses naturally occurring bilirubin conjugated with PEG to encapsulate and deliver hydrophobic anti-cancer drugs with minimal systemic toxicity.

1 investor

Surest offers an ACA-compliant, employer-sponsored health plan for employers with two or more employees, available on self-funded, fully insured, and level funded bases. The plan is designed to give employees clearer, shoppable health care cost information.

1 investor

BindiMaps develops web-based and mobile indoor navigation solutions that help visitors plan routes through buildings and spaces with accessibility features for people with disabilities. The platform serves airports, shopping centers, venues, and other facilities to improve wayfinding and accessibility.

1 investor

BioAgilytix provides bioanalytical laboratory services supporting drug development across all phases, from preclinical through clinical studies. The company operates advanced facilities across North America, Europe, and Australia, specializing in large molecule bioanalysis, LC/MS testing, and diagnostic services for the biopharmaceutical industry.

1 investor

BioAlert Solutions develops qPCR-based monitoring systems for detecting Legionella in cooling towers and water systems across North America. The company serves industries, hospitals, and facility managers to enhance public health safety and ensure regulatory compliance.

1 investor

Bioarchitech develops oncolytic virus therapies and RNA-based immunotherapy candidates for cancer treatment. The company combines expertise in viral engineering, immunology, and preclinical development to advance novel therapeutic platforms.

1 investor

BioAtlantis develops bioactive compounds extracted from seaweed and terrestrial resources to mitigate stress in plants, animals, and humans. The company serves the agricultural crop sector with naturally derived biostimulants and nutraceuticals designed to strengthen natural defence systems.

1 investor

Biobase builds data infrastructure to make clinical data accessible across the healthcare value chain, positioning itself as the "rails" for precision medicine rather than a data marketplace. It serves participants in the healthcare and life sciences sector by connecting data generated during care with downstream medicine development.

1 investor

A medical device company developing a non-invasive endoscopic capsule system for gastrointestinal imaging and diagnosis that patients can use at home while physicians monitor results remotely. The company serves gastroenterologists and patients requiring GI tract assessment.

1 investor

Biocare Medical develops automated immunohistochemistry and molecular pathology instrumentation and reagents for tissue diagnostic testing. The company serves clinical and research laboratories, pharmaceutical companies, and biotechnology firms conducting cancer and infectious disease diagnostics.

1 investor

Biocartesian provides optical pooled screening services for functional genomics research. The company uses its proprietary ARADIA technology to link microscopy-based cellular phenotypes with genetic perturbations, enabling researchers to conduct large-scale CRISPR screens and other genomic studies with visual, spatial, and live-cell readouts.

1 investor

BioChange develops CellFoam, a biodegradable and biocompatible foam scaffold technology for regenerative medicine that supports tissue repair and organ recovery. Its product lines target dental, aesthetic, and human medical uses as well as veterinary care (including products like ReFoam, Revolette, ReGumVet, VetFoam, and vitaloc), with its veterinary line already in the U.S. market.

1 investor